Skip to content
Disclosery

13F-HR filed by DAVENPORT & Co LLC

DAVENPORT & Co LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-01-20, with 1,003 holding rows worth $12,239,178,180.

Accession
0001085146-23-000250
Filer
CIK 887777
Filed
2023-01-20
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 1,003 entries on the cover page, a total value of $12,239,178,180 stated on the cover page (in dollars after the unit check, H1), rows summing to $12,239,178,180 with VALUE read as dollars as filed, 13F file number 028-03200. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Ohr Pharmaceutical Inc64132K102COM40,500$7,703dollars as filed
NEXIMMUNE INC65344D109COM10,500$2,553dollars as filed
CONX Corp212873111Warrant13,000$1,950dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-23-000250this filing2023-01-20acceptance time not in the bulk data set